Thromboembolic Disease
13
5
5
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
The Correlation of Lewis Antigens With VTE
HEPARINS: INTERFERENCE IN ARGATROBAN MEASUREMENT
The Safety and Efficiency of Endovascular Treatment of Acute or Subacute Thromboembolic Occlusions of Lower Extremity.
Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk
Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome
Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)
Prospective, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Endovascular Treatment in Patients With Cerebral Aneurysms Using P64 and P48 Flow-Diverter Stents
Safety of Direct Oral Anticoagulant During Pregnancy
Clearance Of Mucus In Stents (COMIS)
Thromboprophylaxis by Low Molecular Heparin During the Post-partum Period
An Analysis Into the Cause and Preventional Method of Thromboembolic Disease in Gynecological Surgery
Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia
Venous Thrombosis in Turner Syndrome